These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32187778)

  • 1. Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state.
    Huang J; Li J; Zheng S; Lu Z; Che Y; Mao S; Lei Y; Zang R; Liu C; Wang X; Fang L; Sun N; He J
    Cancer Sci; 2020 Jun; 111(6):1876-1886. PubMed ID: 32187778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
    Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinoma.
    Zhang W; Yao S; Huang H; Zhou H; Zhou H; Wei Q; Bian T; Sun H; Li X; Zhang J; Liu Y
    Oncoimmunology; 2021; 10(1):1959977. PubMed ID: 34527427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis of nucleotide metabolism based molecular subtyping and biomarkers in lung adenocarcinoma.
    Luo D; Wang H; Zeng Z; Chen J; Wang H
    Front Immunol; 2024; 15():1430171. PubMed ID: 39148731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Wang J; Zhan X
    Front Immunol; 2021; 12():752643. PubMed ID: 34887858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microenvironment Analysis of Prognosis and Molecular Signature of Immune-Related Genes in Lung Adenocarcinoma.
    Ling B; Huang Z; Huang S; Qian L; Li G; Tang Q
    Oncol Res; 2021 Mar; 28(6):561-578. PubMed ID: 32471520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Characterization and Prognosis of Lactate-Related Genes in Lung Adenocarcinoma.
    Guo Z; Hu L; Wang Q; Wang Y; Liu XP; Chen C; Li S; Hu W
    Curr Oncol; 2023 Feb; 30(3):2845-2861. PubMed ID: 36975430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma.
    Fan T; Zhu M; Wang L; Liu Y; Tian H; Zheng Y; Tan F; Sun N; Li C; He J
    Aging (Albany NY); 2020 Dec; 13(2):2397-2417. PubMed ID: 33318300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell-based molecular subtypes and signature associated with clinical outcome in early-stage lung adenocarcinoma.
    Bao X; Shi R; Zhao T; Wang Y
    Mol Oncol; 2020 May; 14(5):917-932. PubMed ID: 32175651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning reveals two heterogeneous subtypes to assist immune therapy based on lipid metabolism in lung adenocarcinoma.
    Gu X; Wei S; Li Z; Xu H
    Front Immunol; 2022; 13():1022149. PubMed ID: 36238302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis.
    Qin FL; Xu ZY; Yuan LQ; Chen WJ; Wei JB; Sun Y; Li SK
    FEBS Open Bio; 2020 Sep; 10(9):1921-1933. PubMed ID: 32686362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes.
    Isaeva OI; Sharonov GV; Serebrovskaya EO; Turchaninova MA; Zaretsky AR; Shugay M; Chudakov DM
    J Immunother Cancer; 2019 Oct; 7(1):279. PubMed ID: 31665076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
    Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
    Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.
    Liao Y; He D; Wen F
    Immunogenetics; 2021 Oct; 73(5):369-380. PubMed ID: 34302518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses.
    Chen D; Wang Y; Zhang X; Ding Q; Wang X; Xue Y; Wang W; Mao Y; Chen C; Chen Y
    Front Oncol; 2021; 11():581030. PubMed ID: 33747907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma.
    Jie Y; Wu J; An D; Li M; He H; Wang D; Gu A; E M
    Front Pharmacol; 2023; 14():1099927. PubMed ID: 36726580
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic profiling of immune signatures identifies prognostic predictors in lung adenocarcinoma.
    Mao S; Li Y; Lu Z; Che Y; Huang J; Lei Y; Wang Y; Wang X; Liu C; Zheng S; Li N; Li J; Sun N; He J
    Cell Oncol (Dordr); 2020 Aug; 43(4):681-694. PubMed ID: 32462608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma.
    Li D; Yu H; Hu J; Li S; Yan Y; Li S; Sun L; Jiang G; Hou L; Zhang L; Zhang P
    J Transl Med; 2022 Sep; 20(1):423. PubMed ID: 36138435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.